Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New potential analgesics disclosed by Novartis

April 17, 2012

New melanin-concentrating hormone receptor antagonists identified

April 16, 2012

Merck & Co. presents novel PDK1 inhibitors

April 16, 2012

Novel GlyT1 inhibitors developed in Japan

April 16, 2012

Exelixis reports novel PI3K-delta inhibitors

April 16, 2012

Purdue Pharma patents new sodium channel antagonists

April 16, 2012

Bayer Schering discovers novel vasopressin receptor ligands

April 16, 2012

New CYPXVII inhibitors synthesized at Novartis

April 16, 2012

Novel aptamer oligonucleotides designed in Italy

April 16, 2012

Roche divulges new tyrosine-protein kinase JAK inhibitors

April 16, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...